Preventation of thalassemia in Australia.
Southeast Asian J Trop Med Public Health
;
1999 ; 30 Suppl 2(): 94-6
Article
in English
| IMSEAR
| ID: sea-35393
ABSTRACT
Screening for thalassemia and other hemoglobinopathies in the major maternity hospitals in Melbourne, Australia has shown that 6% of the patient population carries a clinically significant genetic abnormality. The most common of these are beta-thalassemia (3%). HbS (1.8%), HbE (0.5%) and alpha0 thalassemia (0.4%). Approximately 60 prenatal diagnoses for the clinically significant combinations of these abnormal genes are performed annually in the 2 major centers of Melbourne and Sydney. The majority of these prenatal diagnoses are for beta-thalassemia major (65%). whilst 11% are for Bart's hydrops fetalis, 8% for HbE/beta-thalassemia. 6% for HbS/beta-thalassemia, 2% for sickle cell anemia and the remaining 8% for other combinations of thalassemia/hemoglobinopathies. Of the 178 patients with beta-thalassemia major, sickle cell disease or beta-thalassemia in combination with HbE or HbS, only 5 are less than 5 years old, reflecting both the success of the screening program and the increasing acceptance by couples of 1st trimester prenatal diagnosis.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Prenatal Diagnosis
/
Australia
/
Thalassemia
/
Female
/
Humans
/
Hemoglobin E
/
Hemoglobin, Sickle
/
Hemoglobins, Abnormal
/
Infant, Newborn
/
Pregnancy
Type of study:
Diagnostic study
/
Etiology study
/
Prognostic study
/
Risk factors
Country/Region as subject:
Oceania
Language:
English
Journal:
Southeast Asian J Trop Med Public Health
Year:
1999
Type:
Article
Similar
MEDLINE
...
LILACS
LIS